These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 1449951)

  • 1. Absolute configuration and conformation of the pure opioid antagonist (+)-2,9 alpha-dimethyl-5-(m-hydroxyphenyl)morphan.
    Froimowitz M; Pangborn W; Cody V
    Chirality; 1992; 4(6):377-83. PubMed ID: 1449951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Probes for narcotic receptor mediated phenomena. 34. Synthesis and structure-activity relationships of a potent mu-agonist delta-antagonist and an exceedingly potent antinociceptive in the enantiomeric C9-substituted 5-(3-hydroxyphenyl)-N-phenylethylmorphan series.
    Hiebel AC; Lee YS; Bilsky E; Giuvelis D; Deschamps JR; Parrish DA; Aceto MD; May EL; Harris LS; Coop A; Dersch CM; Partilla JS; Rothman RB; Cheng K; Jacobson AE; Rice KC
    J Med Chem; 2007 Aug; 50(16):3765-76. PubMed ID: 17625813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Probes for narcotic receptor mediated phenomena. Part 28: new opioid antagonists from enantiomeric analogues of 5-(3-hydroxyphenyl)-N-phenylethylmorphan.
    Hashimoto A; Jacobson AE; Rothman RB; Dersch CM; George C; Flippen-Anderson JL; Rice KC
    Bioorg Med Chem; 2002 Oct; 10(10):3319-29. PubMed ID: 12150879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Probes for narcotic receptor mediated phenomena. 44. Synthesis of an N-substituted 4-hydroxy-5-(3-hydroxyphenyl)morphan with high affinity and selective μ-antagonist activity.
    Iyer MR; Lee YS; Deschamps JR; Dersch CM; Rothman RB; Jacobson AE; Rice KC
    Eur J Med Chem; 2012 Apr; 50():44-54. PubMed ID: 22341895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-Substituted 9beta-methyl-5-(3-hydroxyphenyl)morphans are opioid receptor pure antagonists.
    Thomas JB; Zheng X; Mascarella SW; Rothman RB; Dersch CM; Partilla JS; Flippen-Anderson JL; George CF; Cantrell BE; Zimmerman DM; Carroll FI
    J Med Chem; 1998 Oct; 41(21):4143-9. PubMed ID: 9767649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absolute configurations and conformations of the opioid agonist and antagonist enantiomers of picenadol.
    Froimowitz M; Cody V
    Chirality; 1995; 7(7):518-25. PubMed ID: 7495643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of opioid receptor affinity and efficacy via N-substitution of 9β-hydroxy-5-(3-hydroxyphenyl)morphan: Synthesis and computer simulation study.
    Truong PM; Hassan SA; Lee YS; Kopajtic TA; Katz JL; Chadderdon AM; Traynor JR; Deschamps JR; Jacobson AE; Rice KC
    Bioorg Med Chem; 2017 Apr; 25(8):2406-2422. PubMed ID: 28314512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preferred conformers for the pharmacologically typical and atypical antipodes of phenylmorphan opiates.
    Froimowitz M
    J Med Chem; 1984 Sep; 27(9):1234-7. PubMed ID: 6471078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenylmorphans and analogues: opioid receptor subtype selectivity and effect of conformation on activity.
    Froimowitz M; Pick CG; Pasternak GW
    J Med Chem; 1992 May; 35(9):1521-5. PubMed ID: 1315868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-substituent modulation of opiate agonist/antagonist activity in resolved 3-methyl-3-(m-hydroxyphenyl)piperidines.
    Cheng A; Uyeno E; Polgar W; Toll L; Lawson JA; DeGraw JI; Loew G; Camerman A; Camerman N
    J Med Chem; 1986 Apr; 29(4):531-7. PubMed ID: 3007760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of an opioid kappa receptor selective pure antagonist from a library of N-substituted 4beta-methyl-5-(3-hydroxyphenyl)morphans.
    Thomas JB; Atkinson RN; Namdev N; Rothman RB; Gigstad KM; Fix SE; Mascarella SW; Burgess JP; Vinson NA; Xu H; Dersch CM; Cantrell BE; Zimmerman DM; Carroll FI
    J Med Chem; 2002 Aug; 45(16):3524-30. PubMed ID: 12139463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation of the N-substituent conformation governing potency and mu receptor subtype-selectivity in (+)-(3R, 4R)-dimethyl-4-(3-hydroxyphenyl)piperidine opioid antagonists.
    Thomas JB; Mascarella SW; Rothman RB; Partilla JS; Xu H; McCullough KB; Dersch CM; Cantrell BE; Zimmerman DM; Carroll FI
    J Med Chem; 1998 May; 41(11):1980-90. PubMed ID: 9599247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of an opioid kappa receptor subtype-selective N-substituent for (+)-(3R,4R)-dimethyl-4-(3-hydroxyphenyl)piperidine.
    Thomas JB; Fall MJ; Cooper JB; Rothman RB; Mascarella SW; Xu H; Partilla JS; Dersch CM; McCullough KB; Cantrell BE; Zimmerman DM; Carroll FI
    J Med Chem; 1998 Dec; 41(26):5188-97. PubMed ID: 9857089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 4β-Methyl-5-(3-hydroxyphenyl)morphan opioid agonist and partial agonist derived from a 4β-methyl-5-(3-hydroxyphenyl)morphan pure antagonist.
    Carroll FI; Gichinga MG; Williams JD; Vardy E; Roth BL; Mascarella SW; Thomas JB; Navarro HA
    J Med Chem; 2013 Nov; 56(21):8826-33. PubMed ID: 24144404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enantiomeric conformers of the opioid agonist ketobemidone HCl in the crystal state.
    Froimowitz M; Cody V
    Chirality; 1993; 5(7):560-4. PubMed ID: 7902122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A marked change of receptor affinity of the 2-methyl-5-(3-hydroxyphenyl)morphans upon attachment of an (E)-8-benzylidene moiety: synthesis and evaluation of a new class of sigma receptor ligands.
    Bertha CM; Mattson MV; Flippen-Anderson JL; Rothman RB; Xu H; Cha XY; Becketts K; Rice KC
    J Med Chem; 1994 Sep; 37(19):3163-70. PubMed ID: 7932540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conformational analysis of the opioid phenylmorphan and its 9 alpha-methyl analogue in solution using high-resolution nuclear magnetic resonance spectroscopy.
    DiMeglio CM; Froimowitz M; Makriyannis A
    Pharm Res; 1993 Aug; 10(8):1200-5. PubMed ID: 8415408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Probes for narcotic receptor mediated phenomena. 48. C7- and C8-substituted 5-phenylmorphan opioids from diastereoselective alkylation.
    Lim HJ; Dersch CM; Rothman RB; Deschamps JR; Jacobson AE; Rice KC
    Eur J Med Chem; 2013 Sep; 67():335-43. PubMed ID: 23880358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Racemic and optically active 2,9-dimethyl-5-(m-hydroxyphenyl)morphans and pharmacological comparison with the 9-demethyl homologues.
    Awaya H; May EL; Aceto MD; Merz H; Rogers ME; Harris LS
    J Med Chem; 1984 Apr; 27(4):536-9. PubMed ID: 6708055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Probes for narcotic receptor mediated phenomena. 43. Synthesis of the ortho-a and para-a, and improved synthesis and optical resolution of the ortho-b and para-b oxide-bridged phenylmorphans: compounds with moderate to low opioid-receptor affinity.
    Li F; Folk JE; Cheng K; Kurimura M; Deck JA; Deschamps JR; Rothman RB; Dersch CM; Jacobson AE; Rice KC
    Bioorg Med Chem; 2011 Jul; 19(14):4330-7. PubMed ID: 21684752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.